The Food and Drug Administration yesterday announced a Class I recall of all GE Healthcare Magnetic Resonance Imaging systems with superconducting magnets. According to the notice, there are 12,968 of the MRI systems, including 5,708 in the U.S. In a Feb. 4 announcement, GE Healthcare said it had initiated a “voluntary field corrective action” for all GE MR systems with superconducting magnets manufactured since 1985, because it found that some systems in India have been modified by service personnel or equipment users to disable the Magnet Rundown Unit. “In emergency situations, a disconnected Magnet Rundown Unit could delay removal of a ferrous object from the magnet, potentially resulting in life-threatening injuries,” the company said. According to FDA, the company sent a Jan. 6 letter instructing customers to perform a four-part test to confirm that the MRU is connected to the magnet. If the MRU test does not perform as described in each of the 4 steps, the company “strongly recommends” that they stop using the system and immediately call their GE Healthcare representative, the FDA notice states. Those with questions about the recall may call 262-513-4122, the agency said.

Related News Articles

Headline
More than 880,000 physicians were certified by the American Board of Medical Specialties in 2017, about 20,000 more than in 2016, according to the board’…
Headline
The Centers for Medicare & Medicaid Services has identified the first clinicians eligible to participate in 2018 advanced alternative payment models, based…
Headline
The National Collaborative for Improving the Clinical Learning Environment this week released guidance to help health care system leaders work with clinical…
Headline
In a letter this week, the AHA again urged the Centers for Medicare & Medicaid Services to take specific actions to address and prevent the serious…
Headline
The Centers for Medicare & Medicaid Services should continue to work with national standards body X12 to include the new unique device identifier on its…
Headline
The Centers for Disease Control and Prevention today issued recommendations to help health care providers and laboratories prevent the spread of Candida auris…